IPS-derived corneal cell transplants prove safe, effective
17:24 JST, April 5, 2022
SUITA, Osaka (Jiji Press) — A Japanese research team Monday said it has confirmed that transplants of corneal cells created from induced pluripotent stem, or iPS, cells are safe and effective.
The team, which carried out the world’s first transplant of iPS-derived corneal cells, announced the completion of its clinical research on four transplanted patients.
At a news conference in Suita, Osaka Prefecture, the team, including Osaka University Prof. Koji Nishida, said it aims to start a clinical trial of the treatment next year and put it into practical use within four years after that.
In the clinical research, iPS-derived corneal cells were transplanted into patients suffering from corneal epithelial stem cell deficiency. The disease causes corneas to become cloudy, possibly making patients blind.
The team created sheets of corneal cells derived from iPS cells from other people. The sheets, 3.5 centimeters in diameter and 0.03 to 0.05 millimeters thick, were transplanted into four people in their 30s to 70s.
"Science & Nature" POPULAR ARTICLE
Japanese Government Unveils Liquefied CO2 Transportation Ship ‘Excool’
SLIM Lunar Probe Resumes Operation; Solar Panel Catching Light
Bones from German Cave Rewrite Early History of Homo Sapiens
SLIM Lander Powers Down for Long Lunar Night; JAXA Releases New Batch of Moon Snapshots
JAXA Unveils Portion of 2nd H3 Rocket Set to Launch Feb. 15; Success of Launch Dependent on Functionality of New Equipment
JN ACCESS RANKING
- Japan Eyes 45 B. Yen in Aid for Optical Semiconductors
- Business, Labor Leaders Reaffirm Vow to Raise Wages in Shunto Talks
- Japan’s Job Availability Ratio Rises for 2nd Straight Year
- North Korean Workers in China Riot over Unpaid Wages; 2,000 Occupy Factory, Kill Plant Manager
- M4.8 Earthquake Hits Central Tokyo; No Tsunami Expected